Connect with us

Technology

Hippocratic AI Expands Life Sciences Leadership Team as Pharma and Medtech Demand for Voice AI Agents Accelerates

Published

on

New senior executive hires solidify Hippocratic AI as the category leader in safe generative AI for life sciences

PALO ALTO, Calif., May 20, 2026 /PRNewswire/ — Hippocratic AI, the global leader and pioneer of safe generative AI healthcare agents, today announced new senior executive appointments expanding its life sciences leadership team as the company scales its pharma and medtech business. The appointments — across engineering, medical affairs, commercial growth, and compliance — follow Hippocratic AI’s January 2026 acquisition of Grove AI and the launch of Polaris Life Sciences 5.0, and signal the company’s emergence as the industry’s category-defining voice and conversational AI platform for pharma, biotech, and medtech.

New senior executive hires solidify Hippocratic AI as the category leader in safe generative AI for life sciences

Learn more: https://hippocraticai.com/lifesciences/

“Hippocratic AI is now the established voice and conversational AI platform for life sciences, and we are attracting the most senior leaders in the field,” said Ahad Wahid, President, Life Sciences. “Sri, Toby, John, Himanshu, and Sulaiman together bring more than a century of operating experience across pharma, biotech, and medtech — exactly the bench required to deliver safe, compliant generative AI agents at the scale and standard our life sciences partners demand.”

New Life Sciences Appointments:

Toby Patterson, MD, Senior Vice President, Medical Affairs — Toby joins as Senior Vice President, Medical Affairs, bringing over two decades of senior medical leadership across global pharma. He most recently served as Senior Vice President and Head of U.S. Medical Affairs at Genentech, and previously as Senior Vice President of Global Medical Affairs and Senior Vice President of U.S. Medical Affairs at GSK. Earlier, he held a series of senior medical leadership roles at AbbVie, including Vice President of Medical Operations and Vice President of Immunology and Oncology. Toby holds an MBBS from the University of Adelaide. He leads Hippocratic AI’s medical affairs, quality & pharmacovigilance strategy for life sciences, ensuring the company’s agents meet the clinical, scientific, and ethical bar pharma and medtech partners require.Sulaiman Qazi, Senior Vice President, Chief Compliance Officer, Life Sciences — Sulaiman joins as Senior Vice President, Chief Compliance Officer for Hippocratic AI’s Life Sciences business, bringing more than two decades of global compliance and legal leadership across pharmaceutical, biotechnology, and medical device companies. Most recently he served as SVP & Chief Compliance and Ethics Officer at Bicycle Therapeutics, a clinical-stage biotech. Prior to that, he served as Senior Vice President and Chief Compliance Officer at Seagen, and earlier held senior compliance and legal leadership roles at AbbVie — including Vice President, Business and Enterprise Compliance and Ethics and Compliance Officer, International — as well as Legal Division Counsel at AbbVie. He is known for building right-sized global compliance teams and infrastructure for highly regulated, fast-scaling life sciences organizations. As Chief Compliance Officer, Sulaiman leads the compliance and regulatory framework underpinning Hippocratic AI’s healthcare agents built natively into the Polaris model family.John Kutz, Chief Growth Officer, Biotech — John joins as Chief Growth Officer for the Biotech business, bringing four decades of commercial and consulting leadership across the life sciences industry. He most recently served as General Manager and Senior Partner at EVERSANA, the global commercialization and consulting platform for pharma and biotech, where he led commercial strategy, brand launches, and growth advisory for some of the industry’s most innovative therapies. Earlier in his career, John held senior roles at Arcus Biosciences, Deloitte, and Prophet. He holds an MBA from the Thunderbird School of Global Management and is widely recognized as one of the most respected commercial strategists in biotech. John leads commercial growth for Hippocratic AI’s biotech and emerging-pharma business.Himanshu Sharma, Vice President, Business Development, Life Sciences – Himanshu joins Hippocratic AI as VP of Business Development & Strategic Partnerships, leading life sciences commercial growth and ecosystem partnerships for the company’s generative AI healthcare agents. He brings 15+ years at the intersection of healthcare, life sciences, and technology — most recently in Lower Middle Market Private Equity at J.P. Morgan, with prior experience at McKinsey & Company and across healthcare startups. He holds an MBA from The Wharton School and an MS in Bioinformatics from NYU.Sri Subramaniam, Vice President, Engineering, Life Sciences — Sri joins as Vice President, Engineering for Life Sciences, bringing more than two decades of engineering leadership at the intersection of AI and large-scale consumer and enterprise systems. He most recently served as Director of Software Development at Amazon, where he led Voice Agent teams for Alexa AI (automatic speech recognition run-time, Alexa device AI, Amazon Nova speech-to-speech model). Previously he was VP of AI at Credit Karma, VP of e-commerce engg at Walmart, and a founding leader of Walmart Labs. Sri leads the engineering team building Hippocratic AI’s pharma-, biotech-, and medtech-specific agents on top of the Polaris model family.

With these appointments — and following the Grove AI acquisition and the launch of Polaris Life Sciences 5.0 — Hippocratic AI continues to set the bar for safe, compliant generative AI agents purpose-built for pharma, biotech, and medtech.

About Hippocratic AI

Hippocratic AI has developed the safest generative AI agents for healthcare. The company believes that generative AI has the ability to bring healthcare abundance to every person in the world. The company focuses on building non-diagnostic, patient-facing clinical AI agents and does not allow its agents to be used to prescribe or diagnose. Hippocratic AI has received a total of $404 million in funding and is backed by leading investors, including Andreessen Horowitz, General Catalyst, Kleiner Perkins, Avenir, NVIDIA’s NVentures, Premji Invest, SV Angel, Google’s CapitalG, and numerous health systems. Learn more at https://hippocraticai.com/.

View original content to download multimedia:https://www.prnewswire.com/news-releases/hippocratic-ai-expands-life-sciences-leadership-team-as-pharma-and-medtech-demand-for-voice-ai-agents-accelerates-302778102.html

SOURCE Hippocratic AI

Continue Reading

Technology

WTE MIAMI TO EMBRACE AI-POWERED TECHNOLOGY AS IT SHAPES THE FUTURE OF TRAVEL TRADE

Published

on

By

For the first time, WTE Miami will utilize Fairfest’s SnapCard AI technology, bringing AI-powered matchmaking to the show.

MIAMI, Sept. 22, 2026 /PRNewswire/ — WTE Miami is putting artificial intelligence into action, introducing AI-powered matchmaking for attendees while bringing industry experts together to explore how the technology is transforming travel.

WTE Miami brings AI-powered matchmaking to the show floor for the first time, shaping the future of travel trade.

Taking place October 27–28 at the Miami Beach Convention Center, WTE Miami will incorporate SnapCard AI, Fairfest’s AI-powered matchmaking app, for the first time. The technology allows attendees to describe the business connections they are seeking in their own words, helping identify relevant matches across the show. With 26 NTOs and CVBs confirmed to date, SnapCard AI will connect attendees with destinations and tourism organizations aligned with their business interests.

At OTM 2026, SnapCard AI attracted 7,291 active users from 140 countries, representing 42% adoption despite limited dedicated promotion. 82% of exhibitors secured meetings through the platform, while meeting requests increased 97% year over year.

“SnapCard AI is the first matchmaking platform I’ve used that genuinely feels built for how people actually do business. Bringing it to WTE Miami alongside programming exploring AI in travel means we’re not just talking about the future of this industry—we’re putting it to work on the show floor,” said Simon Press, Managing Director International, Fairfest Media.

WTE Miami’s AI-focused conference programming will include “AI Solutions for the Travel Industry,” featuring Grace Van Hollebeke of Tern and an invited Google speaker; “AI for Travel Professionals,” an MPI Certification Course led by Tim Luepke of MPI Academy; and “AI in Tourism,” a keynote from Karen Ring of Sabre Corp. exploring AI’s impact on travelers and the travel industry.

WTE Miami will take place October 27–28, 2026, at the Miami Beach Convention Center. To register, visit WTE Miami today.

Media Contact:

Olivia Forbis

oforbis@mmgy.com

About WTE Miami

WTE Miami is an international B2B travel trade event connecting destinations, tourism organizations, hotels, airlines, cruise lines, travel technology companies and tourism suppliers with qualified travel buyers across the United States, Canada, Latin America and the Caribbean. The 2026 edition is expected to welcome 500+ exhibitors, 7,000 travel trade professionals, 500 hosted and VIP buyers, and 10,000+ pre-scheduled B2B meetings. Organized by Fairfest Media, WTE Miami takes place October 27–28, 2026, at the Miami Beach Convention Center.

View original content:https://www.prnewswire.com/news-releases/wte-miami-to-embrace-ai-powered-technology-as-it-shapes-the-future-of-travel-trade-302886688.html

SOURCE WTE MIAMI

Continue Reading

Technology

New Jersey Enacts Comprehensive Employee Ownership Finance Legislation Designed with Lafayette Square Institute

Published

on

By

Gov. Sherrill signs bipartisan package establishing Employee Ownership Transition Program and revolving loan fund at NJEDA; LSI releases state playbook laying out a development finance toolkit for states

TRENTON, N.J., Sept. 22, 2026 /PRNewswire/ — New Jersey has enacted comprehensive bipartisan legislation that equips the New Jersey Economic Development Authority (NJEDA) with tools to finance the conversion of businesses to employee ownership. Gov. Mikie Sherrill signed the legislation (A5016/S4218) on September 4, establishing an Employee Ownership Transition Program at NJEDA with reimbursements for feasibility studies, consultative services for firms making the transition, statewide outreach in partnership with the NJ/NY Center for Employee Ownership at Rutgers University, and an Employee Ownership Revolving Loan Fund to finance conversions directly. State Senators Andrew Zwicker and Shirley Turner and Assemblymembers Lisa Swain, Roy Freiman, and Al Barlas sponsored the legislation.

Lafayette Square Institute was proud to support partners in the New Jersey legislature, Governor Sherrill’s office, and NJEDA to achieve this outcome in the Garden State. The legislation builds directly upon recommendations from Lafayette Square Institute’s flagship employee ownership state policy white paper titled Employee Ownership as Economic Development released earlier this year at the National Conference of State Legislators annual convening. The publication details a toolkit for states to expand employee ownership including credit enhancement, institutional capital mobilization, and tax incentives. The playbook also evaluates various strategies to capitalize and fund various tools, build institutional capacity within state government, and implement a comprehensive employee ownership strategy.

The Employee Ownership Revolving Loan Fund revives a tool NJEDA pioneered 50 years ago, when the agency’s first loan financed the employee buyout of the Okonite Company in Passaic County, New Jersey. That loan was repaid and revolved ninefold. Today, Okonite remains 100% employee-owned and has paid more than $300 million in ESOP distributions to its workers. The Fund can be capitalized by state appropriations, federal sources such as U.S. Economic Development Administration grants, and philanthropic capital.

“Governor Sherrill is committed to expanding resources for sustainable business transition plans and employee ownership, protecting jobs, strengthening communities, and creating economic opportunities for workers and their families” said NJEDA Chief Executive Officer Evan Weiss. “We are proud to partner with the Lafayette Square Institute and the NJ/NY Center for Employee Ownership at Rutgers University to ensure the NJEDA’s Employee Ownership Transition Program will provide effective support for entrepreneurs, furthering the Administration’s objective of making New Jersey the best state in the nation to start and grow a business.”

“New Jersey is living through two economic transitions at once: a generation of business owners reaching retirement without a succession plan, and artificial intelligence changing who gains from work. Employee ownership addresses both challenges by keeping companies rooted in our communities and giving the people who build a business a share in what it earns. Lafayette Square Institute brought us this model and the evidence behind it, and this law equips EDA with the tools to use it,” said Senator Andrew Zwicker (D-16).

“This bill is bipartisan for a simple reason: it keeps New Jersey businesses in New Jersey hands without a new mandate or a new tax,” said Assemblyman Al Barlas (R-40). “A revolving loan fund lends, gets repaid, and lends again, which is how the EDA helped Okonite’s workers buy their company fifty years ago. Lafayette Square Institute built this concept on that record, and I was glad to help put it back to work.”

“When you align the financial success of a business with the success of the employees who help run it every day, the benefits are limitless. Employee stock ownership programs offer workers a meaningful path to financial security, while giving local business owners a better way forward in preserving the companies they have worked so hard to build and that make New Jersey flourish,” said Assemblywoman Lisa Swain (D-38). “I’m deeply grateful to Lafayette Square Institute, the NJ/NY Center for Employee Ownership, and the employee owners who helped us get this done.”

“At a moment when returns to capital are pulling away from returns to labor, employee ownership puts workers on both sides of the ledger. New Jersey has now built the financing tools to do just that, and this playbook shows every other state how to do the same,” said Julien Rosenbloom, Senior Associate at Lafayette Square Institute.

“This bipartisan legislative accomplishment is an exciting win for the Garden State at a moment of historically unprecedented business succession across the country,” said Jack Moriarty, Executive Director of Lafayette Square Institute. “By integrating employee ownership into the economic development toolkit, we can preserve and create jobs that build wealth for American workers and families.”

“The evidence from decades of research is consistent: employee-owned companies pay more, keep workers longer, build more retirement wealth, are more productive, and weather downturns with fewer layoffs. The New Jersey/New York Center for Employee Ownership looks forward to partnering with NJEDA so that every owner considering a sale knows selling to employees is a real option. We congratulate Governor Sherrill, Senator Zwicker, and Assemblywoman Swain on this important step,” said William Castellano, Executive Director, New Jersey/New York Center for Employee Ownership, Rutgers School of Management and Labor Relations.

About Lafayette Square Institute

Lafayette Square Institute is a nonprofit policy and data analytics platform committed to aligning private capital with the public interest. Through deep bipartisan relationships, innovative finance tools, and data analysis, LSI mobilizes investment in the people and places that need it.

Media Contact:
Julien Rosenbloom
Lafayette Square Institute
rosenbloom@lafayettesquareinstitute.org

View original content to download multimedia:https://www.prnewswire.com/news-releases/new-jersey-enacts-comprehensive-employee-ownership-finance-legislation-designed-with-lafayette-square-institute-302886690.html

SOURCE Lafayette Square Institute

Continue Reading

Technology

THE CANADIAN FORUM FOR FINANCIAL MARKETS: LOWERING THE PRICE OF CAPITAL MARKETS REGULATION IN CANADA

Published

on

By

TORONTO, Sept. 22, 2026 /CNW/ — Canada wants to attract and mobilize significantly more investments. But businesses and investors still pay for capital markets regulation through a fragmented system of provincial, territorial, and self-regulatory fees that treats Canada’s national capital markets as a collection of local ones.

A new paper from the Canadian Forum for Financial Markets (CFFiM), Fees and Fragmentation: Lowering the Price of Capital Markets Regulation in Canada, recommends that Canada’s system of regulatory fees be reformed as part of Canada’s drive for a “one Canadian economy”, which includes the elimination of interprovincial barriers and increased domestic and foreign investment.   

Canada has 13 provincial and territorial securities regulators as well as the Canadian Investment Regulatory Organization, which operates as a national self-regulatory organization. All of these regulators levy fees on market participants.  The result is a patchwork of charges based largely on individual regulatory structures and priorities rather than a coherent national approach to the fees that are charged to issuers and intermediaries for the benefit of accessing Canada’s capital markets.

This paper identifies overlapping and duplicative fees, inconsistent approaches to cost recovery, and a system of decentralized accountability as resulting in unnecessary costs for market participants, which are ultimately borne on Canadian investors.  These deficiencies contribute to the fragmentation of Canada’s capital markets and negatively impact the attractiveness of Canada’s markets from a global perspective.

“Canada is competing globally for investments.  We should not be adding costs simply because capital crosses a provincial border.” said Laura Paglia, President and CEO of the CFFiM.

The problems associated with Canada’s fee regime could be addressed through a national regulator.  In the absence of those reforms, the CFFiM calls on Canada’s policymakers to establish a simplified and consolidated fee schedule at a net reduction for market participants.  Substantive reform of Canada’s fee regime is needed to allow businesses to expand, to enhance consumer choice, and to promote open, efficient, and competitive capital markets in Canada. 

About CFFiM

The Canadian Forum for Financial Markets (CFFiM)/Forum Canadien des Marchés Financiers (FCMFi) is dedicated to advancing proposals that foster healthy, competitive financial markets and a resilient Canadian economy.

SOURCE Canadian Forum for Financial Markets

Continue Reading

Trending